In a late-stage trial of patients with multiple types of blood cancer, Orca Bio’s allogeneic T-cell immunotherapy doubled the ...
Results showed Orca’s treatment, a purified mix of donor-derived T cells and stem cells, was safer than standard transplant ...
From STAT’s Andrew Joseph: AstraZeneca said this morning it was buying the Belgian cell therapy company EsoBiotec for $425 ...
A T-cell therapy developed by Orca Bio, a private biotech company, significantly reduced the risk of a debilitating immune ...
Stories by SWNS on MSN8h
Girl diagnosed with leukaemia after bruises saved by bone marrow from SingaporeAn eight-year-old girl in the U.K. found a life-saving bone marrow donor from across the world just in time for a critical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results